Making Rift Valley Fever Viral Particles Fluorescent.


Journal

Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969

Informations de publication

Date de publication:
2024
Historique:
medline: 23 7 2024
pubmed: 23 7 2024
entrez: 22 7 2024
Statut: ppublish

Résumé

Rift Valley fever virus (RVFV) is a mosquito-borne pathogen that represents a significant threat to both human and veterinary public health. Since its discovery in the Great Rift Valley of Kenya in the 1930s, the virus has spread across Africa and beyond, now posing a risk of introduction into Southern Europe and Asia. Despite recent progresses, early RVFV-host cell interactions remain largely uncharacterized. In this method chapter, we delineate the procedure for labeling RVFV particles with fluorescent organic dyes. This approach makes it feasible to visualize single viral particles in both fixed and living cells and study RVFV entry into host cells. We provide additional examples with two viruses closely related to RVFV, namely, Toscana virus and Uukuniemi virus. Furthermore, we illustrate how to utilize fluorescent viral particles to examine and quantify each step of the cell entry program of RVFV, which includes state-of-the-art fluorescence-based detection techniques such as fluorescence microscopy, flow cytometry, and fluorimetry.

Identifiants

pubmed: 39039413
doi: 10.1007/978-1-0716-3926-9_12
doi:

Substances chimiques

Fluorescent Dyes 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

165-188

Informations de copyright

© 2024. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Xu Y, Wang X, Jiang L, Zhou Y, Liu Y, Wang F, Zhang L (2023) Natural hosts and animal models for Rift Valley fever phlebovirus. Front Vet Sci 10:1258172. https://doi.org/10.3389/fvets.2023.1258172
doi: 10.3389/fvets.2023.1258172 pubmed: 37929288 pmcid: 10621046
Wright D, Kortekaas J, Bowden TA, Warimwe GM (2019) Rift Valley fever: biology and epidemiology. J Gen Virol 100(8):1187–1199. https://doi.org/10.1099/jgv.0.001296
doi: 10.1099/jgv.0.001296 pubmed: 31310198
Lumley S, Horton DL, Hernandez-Triana LLM, Johnson N, Fooks AR, Hewson R (2017) Rift Valley fever virus: strategies for maintenance, survival and vertical transmission in mosquitoes. J Gen Virol 98(5):875–887. https://doi.org/10.1099/jgv.0.000765
doi: 10.1099/jgv.0.000765 pubmed: 28555542
Freiberg AN, Sherman MB, Morais MC, Holbrook MR, Watowich SJ (2008) Three-dimensional organization of Rift Valley fever virus revealed by cryoelectron tomography. J Virol 82(21):10341–10348. https://doi.org/10.1128/JVI.01191-08
doi: 10.1128/JVI.01191-08 pubmed: 18715915 pmcid: 2573222
Peng K, Lozach PY (2021) Rift Valley fever virus: a new avenue of research on the biological functions of amyloids? Future Virol 16(10):677–689. https://doi.org/10.2217/fvl-2021-0094
doi: 10.2217/fvl-2021-0094
Koch J, Xin Q, Tischler ND, Lozach PY (2021) Entry of Phenuiviruses into mammalian host cells. Viruses 13(2). https://doi.org/10.3390/v13020299
Spiegel M, Plegge T, Pohlmann S (2016) The role of Phlebovirus glycoproteins in viral entry, assembly and release. Viruses 8(7). https://doi.org/10.3390/v8070202
de Boer SM, Kortekaas J, de Haan CA, Rottier PJ, Moormann RJ, Bosch BJ (2012) Heparan sulfate facilitates Rift Valley fever virus entry into the cell. J Virol 86(24):13767–13771. https://doi.org/10.1128/JVI.01364-12
doi: 10.1128/JVI.01364-12 pubmed: 23015725 pmcid: 3503077
Riblett AM, Blomen VA, Jae LT, Altamura LA, Doms RW, Brummelkamp TR, Wojcechowskyj JA (2016) A haploid genetic screen identifies Heparan sulfate proteoglycans supporting Rift Valley fever virus infection. J Virol 90(3):1414–1423. https://doi.org/10.1128/JVI.02055-15
doi: 10.1128/JVI.02055-15 pubmed: 26581979 pmcid: 4719632
Lozach PY, Kuhbacher A, Meier R, Mancini R, Bitto D, Bouloy M, Helenius A (2011) DC-SIGN as a receptor for phleboviruses. Cell Host Microbe 10(1):75–88. https://doi.org/10.1016/j.chom.2011.06.007
doi: 10.1016/j.chom.2011.06.007 pubmed: 21767814
Leger P, Tetard M, Youness B, Cordes N, Rouxel RN, Flamand M, Lozach PY (2016) Differential use of the C-type lectins L-SIGN and DC-SIGN for Phlebovirus endocytosis. Traffic 17(6):639–656. https://doi.org/10.1111/tra.12393
doi: 10.1111/tra.12393 pubmed: 26990254
Ganaie SS, Schwarz MM, McMillen CM, Price DA, Feng AX, Albe JR, Wang W, Miersch S, Orvedahl A, Cole AR, Sentmanat MF, Mishra N, Boyles DA, Koenig ZT, Kujawa MR, Demers MA, Hoehl RM, Moyle AB, Wagner ND, Stubbs SH, Cardarelli L, Teyra J, McElroy A, Gross ML, Whelan SPJ, Doench J, Cui X, Brett TJ, Sidhu SS, Virgin HW, Egawa T, Leung DW, Amarasinghe GK, Hartman AL (2021) Lrp1 is a host entry factor for Rift Valley fever virus. Cell 184(20):5163–5178. e5124. https://doi.org/10.1016/j.cell.2021.09.001
doi: 10.1016/j.cell.2021.09.001 pubmed: 34559985 pmcid: 8786218
Devignot S, Sha TW, Burkard TR, Schmerer P, Hagelkruys A, Mirazimi A, Elling U, Penninger JM, Weber F (2023) Low-density lipoprotein receptor-related protein 1 (LRP1) as an auxiliary host factor for RNA viruses. Life Sci Alliance 6(7):10.26508/lsa.202302005
doi: 10.26508/lsa.202302005
Schwarz MM, Ganaie SS, Feng A, Brown G, Yangdon T, White JM, Hoehl RM, McMillen CM, Rush RE, Connors KA, Cui X, Leung DW, Egawa T, Amarasinghe GK, Hartman AL (2023) Lrp1 is essential for lethal Rift Valley fever hepatic disease in mice. Sci Adv 9(28):eadh2264. https://doi.org/10.1126/sciadv.adh2264
doi: 10.1126/sciadv.adh2264 pubmed: 37450601 pmcid: 10348670
Bermudez-Mendez E, Angelino P, van Keulen L, van de Water S, Rockx B, Pijlman GP, Ciuffi A, Kortekaas J, Wichgers Schreur PJ (2023) Transcriptomic profiling reveals intense host-pathogen dispute compromising homeostasis during acute Rift Valley fever virus infection. J Virol 97(6):e0041523. https://doi.org/10.1128/jvi.00415-23
doi: 10.1128/jvi.00415-23 pubmed: 37306574
de Boer SM, Kortekaas J, Spel L, Rottier PJ, Moormann RJ, Bosch BJ (2012) Acid-activated structural reorganization of the Rift Valley fever virus Gc fusion protein. J Virol 86(24):13642–13652. https://doi.org/10.1128/JVI.01973-12
doi: 10.1128/JVI.01973-12 pubmed: 23035232 pmcid: 3503025
Filone CM, Hanna SL, Caino MC, Bambina S, Doms RW, Cherry S (2010) Rift valley fever virus infection of human cells and insect hosts is promoted by protein kinase C epsilon. PLoS One 5(11):e15483. https://doi.org/10.1371/journal.pone.0015483
doi: 10.1371/journal.pone.0015483 pubmed: 21124804 pmcid: 2991366
Harmon B, Schudel BR, Maar D, Kozina C, Ikegami T, Tseng CT, Negrete OA (2012) Rift Valley fever virus strain MP-12 enters mammalian host cells via caveola-mediated endocytosis. J Virol 86(23):12954–12970. https://doi.org/10.1128/JVI.02242-12
doi: 10.1128/JVI.02242-12 pubmed: 22993156 pmcid: 3497621
Dessau M, Modis Y (2013) Crystal structure of glycoprotein C from Rift Valley fever virus. Proc Natl Acad Sci USA 110(5):1696–1701. https://doi.org/10.1073/pnas.1217780110
doi: 10.1073/pnas.1217780110 pubmed: 23319635 pmcid: 3562824
Guardado-Calvo P, Atkovska K, Jeffers SA, Grau N, Backovic M, Perez-Vargas J, de Boer SM, Tortorici MA, Pehau-Arnaudet G, Lepault J, England P, Rottier PJ, Bosch BJ, Hub JS, Rey FA (2017) A glycerophospholipid-specific pocket in the RVFV class II fusion protein drives target membrane insertion. Science 358(6363):663–667. https://doi.org/10.1126/science.aal2712
doi: 10.1126/science.aal2712 pubmed: 29097548
Halldorsson S, Behrens AJ, Harlos K, Huiskonen JT, Elliott RM, Crispin M, Brennan B, Bowden TA (2016) Structure of a phleboviral envelope glycoprotein reveals a consolidated model of membrane fusion. Proc Natl Acad Sci USA 113(26):7154–7159. https://doi.org/10.1073/pnas.1603827113
doi: 10.1073/pnas.1603827113 pubmed: 27325770 pmcid: 4932967
Hoffmann AB, Mazelier M, Leger P, Lozach PY (2018) Deciphering virus entry with fluorescently labeled viral particles. Methods Mol Biol 1836:159–183. https://doi.org/10.1007/978-1-4939-8678-1_8
doi: 10.1007/978-1-4939-8678-1_8 pubmed: 30151573
Liu SL, Wang ZG, Xie HY, Liu AA, Lamb DC, Pang DW (2020) Single-virus tracking: from imaging methodologies to Virological applications. Chem Rev 120(3):1936–1979. https://doi.org/10.1021/acs.chemrev.9b00692
doi: 10.1021/acs.chemrev.9b00692 pubmed: 31951121 pmcid: 7075663
Gu Y, Lozach PY (2023) Illuminating bunyavirus entry into host cells with fluorescence. Mol Microbiol. https://doi.org/10.1111/mmi.15165
Ouyang T, Liu X, Ouyang H, Ren L (2018) Recent trends in click chemistry as a promising technology for virus-related research. Virus Res 256:21–28. https://doi.org/10.1016/j.virusres.2018.08.003
doi: 10.1016/j.virusres.2018.08.003 pubmed: 30081058
Mohl BP, Roy P (2017) Elucidating virus entry using a tetracysteine-tagged virus. Methods 127:23–29. https://doi.org/10.1016/j.ymeth.2017.08.004
doi: 10.1016/j.ymeth.2017.08.004 pubmed: 28802715 pmcid: 7141927
Liu J, Xu M, Tang B, Hu L, Deng F, Wang H, Pang DW, Hu Z, Wang M, Zhou Y (2019) Single-particle tracking reveals the sequential entry process of the Bunyavirus severe fever with thrombocytopenia syndrome virus. Small 15(6):e1803788. https://doi.org/10.1002/smll.201803788
doi: 10.1002/smll.201803788 pubmed: 30589216
Sakin V, Paci G, Lemke EA, Muller B (2016) Labeling of virus components for advanced, quantitative imaging analyses. FEBS Lett 590(13):1896–1914. https://doi.org/10.1002/1873-3468.12131
doi: 10.1002/1873-3468.12131 pubmed: 26987299
Negi G, Sharma A, Chaudhary M, Gupta D, Harshan KH, Parveen N (2023) SARS-CoV-2 binding to terminal sialic acid of gangliosides embedded in lipid membranes. ACS Infect Dis 9(7):1346–1361. https://doi.org/10.1021/acsinfecdis.3c00106
doi: 10.1021/acsinfecdis.3c00106 pubmed: 37145972
Lopes MM, Paysan J, Rino J, Lopes SM, Pereira de Almeida L, Cortes L, Nobre RJ (2022) A new protocol for whole-brain biodistribution analysis of AAVs by tissue clearing, light-sheet microscopy and semi-automated spatial quantification. Gene Ther 29(12):665–679. https://doi.org/10.1038/s41434-022-00372-z
doi: 10.1038/s41434-022-00372-z pubmed: 36316447
Nathan L, Daniel S (2019) Single Virion tracking microscopy for the study of virus entry processes in live cells and biomimetic platforms. Adv Exp Med Biol 1215:13–43. https://doi.org/10.1007/978-3-030-14741-9_2
doi: 10.1007/978-3-030-14741-9_2 pubmed: 31317494 pmcid: 7122913
Xie E, Ahmad S, Smyth RP, Sieben C (2023) Advanced fluorescence microscopy in respiratory virus cell biology. Adv Virus Res 116:123–172. https://doi.org/10.1016/bs.aivir.2023.05.002
doi: 10.1016/bs.aivir.2023.05.002 pubmed: 37524480
Stolp B, Melican K (2016) Microbial pathogenesis revealed by intravital microscopy: pros, cons and cautions. FEBS Lett 590(13):2014–2026. https://doi.org/10.1002/1873-3468.12122
doi: 10.1002/1873-3468.12122 pubmed: 26938770
Ward EN, Pal R (2017) Image scanning microscopy: an overview. J Microsc 266(2):221–228. https://doi.org/10.1111/jmi.12534
doi: 10.1111/jmi.12534 pubmed: 28248424
Combs CA, Shroff H (2017) Fluorescence microscopy: a concise guide to current imaging methods. Curr Protoc Neurosci 79:2 1 1–2 1 25. https://doi.org/10.1002/cpns.29
doi: 10.1002/cpns.29 pubmed: 28398640
Meier R, Franceschini A, Horvath P, Tetard M, Mancini R, von Mering C, Helenius A, Lozach PY (2014) Genome-wide small interfering RNA screens reveal VAMP3 as a novel host factor required for Uukuniemi virus late penetration. J Virol 88(15):8565–8578. https://doi.org/10.1128/JVI.00388-14
doi: 10.1128/JVI.00388-14 pubmed: 24850728 pmcid: 4135934
Snijder B, Sacher R, Ramo P, Liberali P, Mench K, Wolfrum N, Burleigh L, Scott CC, Verheije MH, Mercer J, Moese S, Heger T, Theusner K, Jurgeit A, Lamparter D, Balistreri G, Schelhaas M, De Haan CA, Marjomaki V, Hyypia T, Rottier PJ, Sodeik B, Marsh M, Gruenberg J, Amara A, Greber U, Helenius A, Pelkmans L (2012) Single-cell analysis of population context advances RNAi screening at multiple levels. Mol Syst Biol 8:579. https://doi.org/10.1038/msb.2012.9
doi: 10.1038/msb.2012.9 pubmed: 22531119 pmcid: 3361004
Sun E, He J, Zhuang X (2013) Live cell imaging of viral entry. Curr Opin Virol 3(1):34–43. https://doi.org/10.1016/j.coviro.2013.01.005
doi: 10.1016/j.coviro.2013.01.005 pubmed: 23395264 pmcid: 3587724
Laughlin LW, Meegan JM, Strausbaugh LJ, Morens DM, Watten RH (1979) Epidemic Rift Valley fever in Egypt: observations of the spectrum of human illness. Trans R Soc Trop Med Hyg 73(6):630–633. https://doi.org/10.1016/0035-9203(79)90006-3
doi: 10.1016/0035-9203(79)90006-3 pubmed: 575446
Woelfl F, Leger P, Oreshkova N, Pahmeier F, Windhaber S, Koch J, Stanifer M, Roman Sosa G, Uckeley ZM, Rey FA, Boulant S, Kortekaas J, Wichgers Schreur PJ, Lozach PY (2020) Novel Toscana virus reverse genetics system establishes NSs as an antagonist of type I interferon responses. Viruses 12(4). https://doi.org/10.3390/v12040400
Pettersson R, Kaariainen L (1973) The ribonucleic acids of Uukuniemi virus, a noncubical tick-borne arbovirus. Virology 56(2):608–619. https://doi.org/10.1016/0042-6822(73)90062-7
doi: 10.1016/0042-6822(73)90062-7 pubmed: 4796549
Mazelier M, Rouxel RN, Zumstein M, Mancini R, Bell-Sakyi L, Lozach PY (2016) Uukuniemi Virus as a Tick-Borne Virus Model. J Virol 90(15):6784–6798. https://doi.org/10.1128/JVI.00095-16
doi: 10.1128/JVI.00095-16 pubmed: 27194760 pmcid: 4944291
Schneider CA, Rasband WS, Eliceiri KW (2012) NIH image to ImageJ: 25 years of image analysis. Nat Methods 9(7):671–675. https://doi.org/10.1038/nmeth.2089
doi: 10.1038/nmeth.2089 pubmed: 22930834 pmcid: 5554542
Sbalzarini IF, Koumoutsakos P (2005) Feature point tracking and trajectory analysis for video imaging in cell biology. J Struct Biol 151(2):182–195. https://doi.org/10.1016/j.jsb.2005.06.002
doi: 10.1016/j.jsb.2005.06.002 pubmed: 16043363
Engel S, Heger T, Mancini R, Herzog F, Kartenbeck J, Hayer A, Helenius A (2011) Role of endosomes in simian virus 40 entry and infection. J Virol 85(9):4198–4211. https://doi.org/10.1128/JVI.02179-10
doi: 10.1128/JVI.02179-10 pubmed: 21345959 pmcid: 3126231
Johannsdottir HK, Mancini R, Kartenbeck J, Amato L, Helenius A (2009) Host cell factors and functions involved in vesicular stomatitis virus entry. J Virol 83(1):440–453. https://doi.org/10.1128/JVI.01864-08
doi: 10.1128/JVI.01864-08 pubmed: 18971266

Auteurs

Yu Gu (Y)

IVPC UMR754, INRAE, Université Claude Bernard Lyon 1, EPHE, PSL Research University, Lyon, France.

Jana Koch (J)

IVPC UMR754, INRAE, Université Claude Bernard Lyon 1, EPHE, PSL Research University, Lyon, France.

Céline Garnier (C)

IVPC UMR754, INRAE, Université Claude Bernard Lyon 1, EPHE, PSL Research University, Lyon, France.

Alexandra Erny (A)

IVPC UMR754, INRAE, Université Claude Bernard Lyon 1, EPHE, PSL Research University, Lyon, France.

Pierre-Yves Lozach (PY)

IVPC UMR754, INRAE, Université Claude Bernard Lyon 1, EPHE, PSL Research University, Lyon, France. pierre-yves.lozach@inrae.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH